Skip to Main Content

Paper Details

Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy.
1
2023
COVID-19, Delta, ITS, Omicron variant, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 infection, coronavirus disease 2019, molnupiravir, monoclonal antibodies, nirmatrelvir, patients, remdesivir, ritonavir, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, sotrovimab
Author NameAffiliation
Gianluca TrifiròUniversity of Verona
  • 1 - 1

Datasets

Release 1.2